GK

Guttahalli Krishnappa Shridhar

Active Director Director DIN 06973473
DIN 06973473 First appointment Mar 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2015
Shareholding value •••• Premium profile

About Guttahalli Krishnappa Shridhar

Data last updated:

Guttahalli Krishnappa Shridhar is a Director at Dhanvanthri Speciality Pharma Private Limited (since 2015) and Whole-Time Director at Dhanvanthri Super Speciality Private Limited (since 2023). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹299 Cr; the largest is Dhanvanthri Speciality Pharma Private Limited at ₹173 Cr (FY 2024).

DIN 06973473
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2015
Oldest Company Age 11 yrs
Largest company Dhanvanthri Speciality Pharma Private Limited · ₹173 Cr (FY 2024)
Combined revenue ₹299 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20152015₹173 Cr (FY 2024)Active
Whole-Time Director11 Aug 20232023₹126 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Dhanvanthri Speciality Pharma Private Limited
Dhanvanthri Super Speciality Private Limited
Premium access

Shareholding and investment profile for Guttahalli Krishnappa Shridhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Guttahalli Krishnappa Shridhar

Guttahalli Krishnappa Shridhar currently holds 2 directorships: Dhanvanthri Speciality Pharma Private Limited (Director, since 31 Mar 2015, revenue ₹173 Cr (FY 2024)); Dhanvanthri Super Speciality Private Limited (Whole-Time Director, since 11 Aug 2023, revenue ₹126 Cr (FY 2025)).

Guttahalli Krishnappa Shridhar was first appointed on 31 Mar 2015 as Director at Dhanvanthri Speciality Pharma Private Limited. The most recent appointment on record is 11 Aug 2023 at Dhanvanthri Super Speciality Private Limited.

The 2 current companies of Guttahalli Krishnappa Shridhar that report revenue have a combined latest revenue of ₹299 Cr: Dhanvanthri Speciality Pharma Private Limited ₹173 Cr (FY 2024); Dhanvanthri Super Speciality Private Limited ₹126 Cr (FY 2025).

The current boards of Guttahalli Krishnappa Shridhar's companies include Bhavya Balaraj (Dhanvanthri Speciality Pharma Private Limited), Kushal Ashok Shah (Dhanvanthri Super Speciality Private Limited), Manish Kumar (Dhanvanthri Super Speciality Private Limited), Nikesh Kesarimal Oswal (Dhanvanthri Super Speciality Private Limited), Sambit Mohanty (Dhanvanthri Super Speciality Private Limited), Satyendra Tiwari (Dhanvanthri Super Speciality Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available